Stay updated on OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Sign up to get notified when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.

Latest updates to the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page
- Check5 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5. This signals a newer version of the page rather than a content change.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe revision tag at the bottom of the page was updated to v3.6.4, indicating a newer version of the study record.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page's revision was updated to v3.6.3 from v3.6.2, indicating a minor update to the entry rather than substantive changes to the study details.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2 on the page, signaling a minor update to the ClinicalTrials.gov entry without changing the study details.SummaryDifference0.0%

- Check63 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', and new help/navigation sections were added to guide users on reading the study record and joining the study. The header formatting changed from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag was updated to v3.6.0.SummaryDifference0.3%

- Check70 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, reflecting a small metadata update to the study record.SummaryDifference0.0%

Stay in the know with updates to OPUS Clinical Trial: Natalizumab in Focal Epilepsy
Enter your email address, and we'll notify you when there's something new on the OPUS Clinical Trial: Natalizumab in Focal Epilepsy page.